Cargando…
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833057/ https://www.ncbi.nlm.nih.gov/pubmed/32679085 http://dx.doi.org/10.1016/S1473-3099(20)30584-3 |
_version_ | 1783641978308657152 |
---|---|
author | Perez-Saez, Javier Lauer, Stephen A Kaiser, Laurent Regard, Simon Delaporte, Elisabeth Guessous, Idris Stringhini, Silvia Azman, Andrew S |
author_facet | Perez-Saez, Javier Lauer, Stephen A Kaiser, Laurent Regard, Simon Delaporte, Elisabeth Guessous, Idris Stringhini, Silvia Azman, Andrew S |
author_sort | Perez-Saez, Javier |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7833057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78330572021-01-26 Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland Perez-Saez, Javier Lauer, Stephen A Kaiser, Laurent Regard, Simon Delaporte, Elisabeth Guessous, Idris Stringhini, Silvia Azman, Andrew S Lancet Infect Dis Correspondence Elsevier Ltd. 2021-04 2020-07-14 /pmc/articles/PMC7833057/ /pubmed/32679085 http://dx.doi.org/10.1016/S1473-3099(20)30584-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Perez-Saez, Javier Lauer, Stephen A Kaiser, Laurent Regard, Simon Delaporte, Elisabeth Guessous, Idris Stringhini, Silvia Azman, Andrew S Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title | Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title_full | Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title_fullStr | Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title_full_unstemmed | Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title_short | Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
title_sort | serology-informed estimates of sars-cov-2 infection fatality risk in geneva, switzerland |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833057/ https://www.ncbi.nlm.nih.gov/pubmed/32679085 http://dx.doi.org/10.1016/S1473-3099(20)30584-3 |
work_keys_str_mv | AT perezsaezjavier serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT lauerstephena serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT kaiserlaurent serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT regardsimon serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT delaporteelisabeth serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT guessousidris serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT stringhinisilvia serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT azmanandrews serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland AT serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland |